Skip to content

Wave Life Sciences WVE Asset turnover

Asset turnover at other companies

Eli Lilly logo
Eli LillyLLY
0.7×+0.1×
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
0.7×
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
0.3×+0.1×
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
+0.7×
ALN
Alnylam PharmaceuticalsALNY
0.9×+0.3×
Beam Therapeutics logo
Beam TherapeuticsBEAM
0.1×+0.1×

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.11B+9.2%
Enterprise value$577.44M-27.2%
P/S14.6×-11.8×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%
Debt / equity-0.1×
Current ratio11.3×+8.3×

Where this comes from

Calculated from Wave Life Sciences’s reported figures.

Based on trailing twelve months.

The official record: Wave Life Sciences’s 10-Q, filed August 8, 2024, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's asset turnover?
Wave Life Sciences (WVE) reported asset turnover of 0.5× in Q2 2024.
How has Wave Life Sciences's asset turnover changed year-over-year?
Wave Life Sciences's asset turnover increased by 205.4% year-over-year, from 0.2× to 0.5×.
What is the long-term trend for Wave Life Sciences's asset turnover?
Over 3 years (2020 to 2023), Wave Life Sciences's asset turnover has grown at a 96.1% compound annual growth rate (CAGR), from 0.1× to 0.5×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.